iNtRON Biotechnology, Inc. (048530.KQ) KOE

2,715.00

-5(-0.18%)

Updated at June 02 03:30PM

Currency In KRW

Valuation

Market Cap110.99B
Enterprise Value86.72B
P/E Ratio-8.93
PEG Ratio0.13
Price/Sales Ratio13.03
Price/Book Ratio1.32
Enterprise/Revenue9.93
Enterprise/EBITDA-10.11

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-1.47
Operating Margin-1.28

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.13

Income Statement

Revenue5.74B
Revenue/Share206.25
Gross Profit2.15B
EBITDA-5.96B
Net Income-9.26B
Diluted EPS-271.16

Balance Sheet

Total Cash30.22B
Total Cash/Share968.17
Total Debt5.08B
Total Debt/Equity0.08
Current Ratio9.81
Book Value Per Share2,064.42

Price History

52-Week Change-37.51
52-Week High7,010
52-Week Low2,630
Moving Average 50 Days3,632.9
Moving Average 200 Days3,742.7

Statistics

Average Volume1.24M
Shares Outstanding30.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate100
Trailing Annual Dividend Yield3.68
Payout Ratio0
Last Split Factor2:1
Last Split DateJanuary 10, 2019